Literature DB >> 3898757

Immune cytolysis viewed as a stimulatory process of the target.

R Tirosh, G Berke.   

Abstract

Humoral and cellular mechanisms of immune cytolysis, as effected by antibody and complement (Ab + C') or by cytolytic T lymphocytes (CTL), have traditionally been considered the end result of early but terminal membrane damage, in turn causing colloid-osmotic lysis of the target cell. A comprehensive theory explaining and relating known prelytic cellular events to subsequent membrane damage is lacking, nor is there a specific picture as to the role and mode of action of Ca2+, which appears to be involved in both complement- and cell-mediated cytolysis (C'MC and CMC, respectively). Recent studies are in support of the view that both Ab + C' and CTL induce a comparable series of prelytic events, in the TC, initiated by membrane depolarization, which in turn bring about voltage-dependent Ca2+ influx or its intracellular release. Persistent elevation of cytosolic Ca2+ can induce massive stimulation of cellular ATPases (actomyosin, Ca2+) and cause exhaustive depletion of ATP. Consequently, Na+-pumping is slowed down and colloid-osmotic lysis ensues. Hence, in our view, membrane damage in immune cytolysis is the result rather than the cause of intracellular events culminating in lysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3898757     DOI: 10.1007/978-1-4684-8326-0_31

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Immunological rejection of heart transplant: how lytic granules from cytotoxic T lymphocytes damage guinea pig ventricular myocytes.

Authors:  O Binah; S Marom; I Rubinstein; R B Robinson; G Berke; B F Hoffman
Journal:  Pflugers Arch       Date:  1992-02       Impact factor: 3.657

2.  Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans.

Authors:  M R Hidore; J W Murphy
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.